Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent H Summers

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medical Economics|May 18, 2011
Economic impact of potential drug-drug interactions in opioid analgesicsKent H Summers, R Amy Puenpatom, Niveda Rajan, et al.
American Health & Drug Benefits|July 4, 2014
Daily average consumption of 2 long-acting opioids: an interrupted time series analysisR Amy Puenpatom, Sheryl L Szeinbach, Larry Ma, et al.
Annals of General Psychiatry|November 20, 2012
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision modelNicolas M Furiak, James C Gahn, Robert W Klein, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2005
Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOLDonald M Bushnell, Mona L Martin, Kent H Summers, et al.
Diabetes Care|January 5, 2002
Productivity and medical costs of diabetes in a large employer populationScott Ramsey, Kent H Summers, Stephanie A Leong, et al.
Journal of Managed Care Pharmacy : JMCP|June 11, 2011
A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tabletsMark Rubino, Kent H Summers, Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 29, 2011
Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Journal of Managed Care Pharmacy : JMCP|June 7, 2005
Comparison of costs and utilization between users of insulin lispro versus users of regular insulin in a managed care settingKristina Chen, Eunice Y Chang, Kent H Summers, et al.
Pain Practice : the Official Journal of World Institute of Pain|January 5, 2011
Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptionsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 20, 2011
Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medical Economics|May 18, 2011
Economic impact of potential drug-drug interactions in opioid analgesicsKent H Summers, R Amy Puenpatom, Niveda Rajan, et al.
American Health & Drug Benefits|July 4, 2014
Daily average consumption of 2 long-acting opioids: an interrupted time series analysisR Amy Puenpatom, Sheryl L Szeinbach, Larry Ma, et al.
Annals of General Psychiatry|November 20, 2012
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision modelNicolas M Furiak, James C Gahn, Robert W Klein, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 13, 2005
Quality of life of women with urinary incontinence: cross-cultural performance of 15 language versions of the I-QOLDonald M Bushnell, Mona L Martin, Kent H Summers, et al.
Diabetes Care|January 5, 2002
Productivity and medical costs of diabetes in a large employer populationScott Ramsey, Kent H Summers, Stephanie A Leong, et al.
Journal of Managed Care Pharmacy : JMCP|June 11, 2011
A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tabletsMark Rubino, Kent H Summers, Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 29, 2011
Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Journal of Managed Care Pharmacy : JMCP|June 7, 2005
Comparison of costs and utilization between users of insulin lispro versus users of regular insulin in a managed care settingKristina Chen, Eunice Y Chang, Kent H Summers, et al.
Pain Practice : the Official Journal of World Institute of Pain|January 5, 2011
Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptionsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pain Practice : the Official Journal of World Institute of Pain|September 20, 2011
Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioidsJoseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, et al.
Pageof 3